Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23
Phase 31

Trial Status

Completed2
Terminated2
Other1

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT04485026Phase 2Withdrawn
Local Consolidative Radiotherapy for Oligoprogressive in Non-small Cell Lung Carcinoma
Non Small Cell Lung CancerOligoprogressive
PrincipalinvestigatorStart date: 2020-11-04
NCT04398199Phase 2Terminated
Study of Hypofractionated Radiotherapy Alone in Locally Advanced Nonsmall Cell Lung Cancer Patients
Nonsmall Cell Lung Cancer Stage IIINonsmall Cell Lung Cancer, Stage II
PrincipalinvestigatorStart date: 2020-10-16
NCT04040244Not ApplicableTerminated
Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis
Nonsmall Cell Lung Cancer Stage IIIPneumonitis
PrincipalinvestigatorStart date: 2019-12-09
NCT03861091Phase 2Completed
Prophylactic Risedronate for Patients With Peripheral Lung Tumors Treated With SBRT
Lung Neoplasm
PrincipalinvestigatorStart date: 2019-07-12
NCT03867175Phase 3Completed
Immunotherapy With or Without SBRT in Patients With Stage IV Non-small Cell Lung Cancer
Metastatic Lung CancerStage IV Lung Cancer
PrincipalinvestigatorStart date: 2019-06-24

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Arun Rajan, M.D.

National Cancer Institute (NCI)

Related
17 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungLung Neoplasms

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

shun lu, MD

Shanghai Chest Hospital

Related
13 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungLung Neoplasms
Similarity Score8%

Puma

Biotechnology

Related
26 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungLung Neoplasms
Similarity Score8%

David S Schrump, M.D.

National Cancer Institute (NCI)

Related
21 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungLung Neoplasms

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung
Similarity Score4%

Toshimitsu Tokimoto

Astrazeneca KK

Related
16 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung
Similarity Score4%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Zhaohui Zhu, MD

Peking Union Medical College Hospital

Related
19 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung
Similarity Score4%

You Lu, MD

West China Hospital

Related
18 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung
Similarity Score4%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Stage IV Lung Cancer
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT04485026Phase 2PrincipalInvestigator

Local Consolidative Radiotherapy for Oligoprogressive in Non-small Cell Lung Carcinoma

Non Small Cell Lung CancerOligoprogressive
Withdrawn
NCT04398199Phase 2PrincipalInvestigator

Study of Hypofractionated Radiotherapy Alone in Locally Advanced Nonsmall Cell Lung Cancer Patients

Nonsmall Cell Lung Cancer Stage IIINonsmall Cell Lung Cancer, Stage II
Terminated
NCT04040244Not ApplicablePrincipalInvestigator

Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis

Nonsmall Cell Lung Cancer Stage IIIPneumonitis
Terminated
NCT03861091Phase 2PrincipalInvestigator

Prophylactic Risedronate for Patients With Peripheral Lung Tumors Treated With SBRT

Lung Neoplasm
Completed
NCT03867175Phase 3PrincipalInvestigator

Immunotherapy With or Without SBRT in Patients With Stage IV Non-small Cell Lung Cancer

Metastatic Lung CancerStage IV Lung Cancer
Completed

All 5 trials loaded